Cleveland BioFund, a new venture group in Cleveland, is launching a partnership with Newsummit Pharmaceutical Group, a Shanghai-based biotechnology development company, to fund and support revenue-stage US medical device companies looking to enter the China market, and Chinese medical device companies looking to enter the US market. The partners announced that $30 million of a targeted $100 million in funding is available now. BioEnterprise will assist the groups in identifying and supporting opportunities. Cleveland BioFund is a new project launched by the group behind the Cleveland International Fund, a real estate investment fund.
To read the full, original article click on this link: New $30 Million China-Cleveland Biomedical Fund Launched
